Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Motor Activity 4Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Obesity 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Skin Neoplasms 1Sarcopenia 1Renal Insufficiency, Chronic 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Overweight 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Inflammation 1Hematopoietic and Lymphatic System Neoplasm 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 16fludarabine 9Cytarabine 9venetoclax 8Mycophenolic Acid 8Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6Tacrolimus 5Daunorubicin 5Cyclosporine 5ruxolitinib 4ponatinib 4Rituximab 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4Etoposide 4blinatumomab 3asciminib 3Vincristine 3Prednisone 3Mercaptopurine 3Inotuzumab Ozogamicin 3Dexamethasone 3Azacitidine 3revumenib 2quizartinib 2pegfilgrastim 2nilotinib 2ibrutinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Resistance Training × 90 days × Clear all
NCT05763563 2026-03-31

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡